Related Experiment Video
Updated: Feb 12, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy
Hiromi Ihoriya1, Hirotsugu Yamamoto1, Taihei Yamada1
1Department of Emergency and Critical Care Medicine Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences 2-5-1 Shikata-cho, Kita-ku Okayama-shi Okayama 700-8558 Japan.
Abstract:
Hyperammonemia is a rare adverse effect of 5-fluorouracil (5-FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5-FU therapy.
Related Concept Videos
Receiver Operating Characteristic Plot
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Patient-centered Care

